Ignite Creation Date:
2025-12-24 @ 7:46 PM
Ignite Modification Date:
2026-01-12 @ 3:15 PM
Study NCT ID:
NCT03208803
Status:
COMPLETED
Last Update Posted:
2022-07-20
First Post:
2017-06-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of JAK2 Inhibitor and Erythropoiesis-stimulating Agent in Myelofibrosis
Sponsor:
Centre Hospitalier Annecy Genevois
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
15-10_Ruxo-EPO
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None